The results confirmed that the SREBP pathway is required for hepatic steatosis in PTENΔL mice; however, unexpectedly, SCAP/SREBP pathway inhibition markedly exacerbated liver injury, fibrosis, and carcinogenesis in PTENΔL mice. Here, SCAP is linked to Hepatic steatosis.